Suspension of trading
Sector Oncternal Therapeutics, Inc.
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 02/12/2024 GMT
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/07/25 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/07/25 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -.--% | -.--% | -.--% | -91.52% | -99.42% | - | 1.56M | |
| -0.18% | +4.35% | -5.13% | +9.05% | +4.46% | +4.23% | +31.79% | -26.06% | +204.33% | 47.86B | |
| -0.83% | -0.36% | +3.09% | +56.39% | +18.83% | +43.66% | +34.77% | +2.13% | +237.31% | 44.46B | |
| -0.84% | +4.86% | -2.53% | +32.18% | +20.14% | +10.92% | +91.52% | -5.30% | +1,097.11% | 41.85B | |
| -1.10% | -2.64% | -8.94% | +12.52% | +139.47% | +331.49% | +535.80% | +497.56% | - | 41.34B | |
| -0.62% | +0.11% | -7.75% | +10.53% | +2.91% | +1.12% | +46.02% | -24.16% | +128.88% | 30.04B | |
| -2.07% | +0.12% | -0.58% | +30.34% | +9.88% | +24.39% | +154.30% | +216.10% | +1,988.49% | 17.59B | |
| -3.55% | +1.95% | +4.56% | +16.74% | +22.05% | +21.97% | +38.83% | -38.00% | +86.28% | 15.69B | |
| -6.08% | -9.92% | -11.91% | -6.48% | - | - | - | - | - | 15.6B | |
| -0.78% | +9.46% | +5.37% | +57.56% | +29.70% | -8.96% | - | - | - | 13.93B | |
| -2.73% | +1.43% | -6.05% | +48.62% | +39.03% | +84.58% | +38.93% | -39.05% | +235.10% | 13.61B | |
| -1.92% | -5.77% | -4.84% | +14.88% | -10.05% | -3.80% | -34.55% | -41.77% | +114.30% | 12.89B | |
| -2.54% | +9.35% | +24.77% | +235.81% | +227.70% | +153.42% | +107.23% | +27.39% | +1,725.11% | 11.76B | |
| -0.04% | +0.26% | +0.28% | +28.90% | +23.31% | +37.04% | +4.57% | -45.97% | +167.75% | 11.38B | |
| +1.26% | +4.33% | -6.17% | +89.96% | +58.35% | +32.14% | +61.30% | -52.41% | - | 11.18B | |
| -5.40% | -0.74% | -3.61% | +17.53% | +48.40% | +126.99% | +559.83% | +79.78% | - | 10.15B | |
| -4.39% | -2.90% | -10.12% | +16.59% | +58.80% | +113.19% | +710.64% | +670.56% | +715.88% | 9.39B | |
| +0.05% | +1.89% | -0.82% | +17.50% | -7.66% | -8.96% | -0.66% | -28.58% | +41.45% | 9.04B | |
| -3.01% | -7.35% | -17.68% | -2.16% | -30.40% | +19.20% | +416.65% | +160.65% | +1,024.83% | 8.62B | |
| -6.16% | -8.70% | -24.96% | -7.61% | -4.28% | +480.49% | +1,206.11% | -6.29% | - | 8.39B | |
| Average | -3.20% | -0.08% | -3.65% | +33.94% | +34.25% | +77.01% | +217.31% | +69.29% | +597.45% | 18.74B | |
| Weighted average by Cap. | -1.47% | +1.39% | -3.43% | +31.99% | +37.18% | +75.57% | +179.29% | +81.08% | +544.37% |
- Stock Market
- Stocks
- ONCT Stock
- Sector Oncternal Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
